GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Genpharmasec Ltd (BOM:531592) » Definitions » Tax Expense

Genpharmasec (BOM:531592) Tax Expense : ₹8.9 Mil (TTM As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Genpharmasec Tax Expense?

Genpharmasec's tax expense for the months ended in Dec. 2024 was ₹5.1 Mil. Its tax expense for the trailing twelve months (TTM) ended in Dec. 2024 was ₹8.9 Mil.


Genpharmasec Tax Expense Historical Data

The historical data trend for Genpharmasec's Tax Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Genpharmasec Tax Expense Chart

Genpharmasec Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Tax Expense
Get a 7-Day Free Trial Premium Member Only Premium Member Only 1.96 2.52 -2.34 -8.43 4.20

Genpharmasec Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Tax Expense Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -0.34 3.78 2.00 -1.99 5.12

Genpharmasec Tax Expense Calculation

Tax paid by the company. It is computed in by multiplying the income before tax number, as reported to shareholders, by the appropriate tax rate. In reality, the computation is typically considerably more complex due to things such as expenses considered not deductible by taxing authorities ("add backs"), the range of tax rates applicable to various levels of income, different tax rates in different jurisdictions, multiple layers of tax on income, and other issues.

Tax Expense for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was ₹8.9 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Genpharmasec  (BOM:531592) Tax Expense Explanation

In the long run, income before tax and taxable income will likely be more similar than they are in any given period. If the one is less in earlier years, then it will be greater in later years. Deferred taxes will reverse themselves in the long run and in total will zero out, unless there is something like a change in tax rates in the intervening period. A deferred tax payable results from a tax break in the early years and will reverse itself in later years; a deferred tax receivable results from more taxes being paid in early years than the tax expense reported to shareholders and will again reverse itself in later years. The deferred tax amount is computed by estimating the amount and the timing of the reversal and multiplying that by the appropriate tax rates.


Genpharmasec Tax Expense Related Terms

Thank you for viewing the detailed overview of Genpharmasec's Tax Expense provided by GuruFocus.com. Please click on the following links to see related term pages.


Genpharmasec Business Description

Traded in Other Exchanges
N/A
Address
Akurli Road, Office No. 104 and 105, 1st Floor, Gundecha Industrial Premises Co-op Soc. Ltd., Kandivali (East), Mumbai, MH, IND, 400101
Genpharmasec Ltd is engaged in pharmaceutical activities and services. The company operates in two reportable segments namely; Diagnostic Pharma Equipment which includes pharmaceutical, medicinal, and medicated preparations, patent medicines, drugs, and herbs, and pharmaceutical, medicinal, and proprietary and industrial preparations, compounds, and articles of kinds, chemists, druggists, and chemical manufacturers. The Trading in the Securities segment of the company invests in the secondary securities market. The Diagnostic Pharma Equipment segment is the key revenue generator for the group.

Genpharmasec Headlines

No Headlines